MONTREAL, QUEBEC--(Marketwire - April 9, 2008) - NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Adaltis Inc. (TSX:ADS), an international in vitro diagnostic (IVD) company, today announced that it has filed a final short form prospectus in each of the provinces of Canada relating to its previously announced $14.9 million rights offering to its shareholders.
